Clinical Trial Update: A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating niraparib in ovarian cancer patients who had three or four prior chemotherapy regimens; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Neoplasms

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Tesaro, Inc. | Conditions: Ovarian Neoplasms, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-04-09